Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MCRI | Common Stock | Options Exercise | +31.7K | +52.38% | 92.1K | May 14, 2021 | Direct | F1 | ||
transaction | MCRI | Common Stock | Tax liability | -$1.79M | -24.6K | -26.72% | $72.88 | 67.5K | May 14, 2021 | Direct | |
transaction | MCRI | Common Stock | Sale | -$2.11M | -29.7K | -44% | $70.93 | 37.8K | May 17, 2021 | Direct | |
transaction | MCRI | Common Stock | Sale | -$1.57M | -22K | -58.19% | $71.58 | 15.8K | May 18, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MCRI | Options / Right to Buy | Options Exercise | $0 | +31.7K | +31.15% | $0.00 | 133K | May 14, 2021 | Common Stock | 31.7K | Direct | F1 | |
holding | MCRI | Options / Right to Buy | 133K | May 14, 2021 | Common Stock | 15K | $60.62 | Direct | ||||||
holding | MCRI | Options / Right to Buy | 133K | May 14, 2021 | Common Stock | 33.3K | Direct | F2 | ||||||
holding | MCRI | Options / Right to Buy | 133K | May 14, 2021 | Common Stock | 33.3K | Direct | F3 | ||||||
holding | MCRI | Options / Right to Buy | 133K | May 14, 2021 | Common Stock | 16.7K | $42.74 | Direct | ||||||
holding | MCRI | Options / Right to Buy | 133K | May 14, 2021 | Common Stock | 16.7K | $42.74 | Direct | ||||||
holding | MCRI | Options / Right to Buy | 133K | May 14, 2021 | Common Stock | 6.67K | $47.81 | Direct | ||||||
holding | MCRI | Options / Right to Buy | 133K | May 14, 2021 | Common Stock | 11.7K | $47.05 | Direct |
Id | Content |
---|---|
F1 | Mr. David Farahi net exercised the following grants:(i)13,333 stock options at $45.55 exercise price, which vested on February 1, 2021; ii)1,667 stock options at $42.46 exercise price , which vested on March 1, 2021; and (iii)16,666 stock options at $42.74 exercise price, which vested on May 3, 2021.All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |
F2 | In 2020 Mr. Farahi was granted 33,333 stock options, as follow: (i) 13,333 stock options at $53.680 exercise price, which vest on February 1, 2023; (ii) 1,667 stock options at $47.28 exercise price, which vest on March 1, 2023; and (iii) 18,333 stock options at $44.60 exercise price, which vest on September 30, 2023. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |
F3 | In 2019 Mr. Farahi was granted 33,333 stock options, as follow: (i) 13,334 stock options at $43.30 exercise price, which vest on February 1, 2022; (ii) 1,666 stock options at $44.31 exercise price, which vest on March 1, 2022; (iii) 6,666 stock options at $45.69 exercise price, which vest on August 1, 2022 and (v) 11,667 stock options at $44.38 exercise price, which vest on September 1, 2022. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |